Apollo Endosurgery
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, Apollo Endosurgery sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).
Apollo Endosurgery: 7 sponsored US clinical trials, none currently recruiting.
Apollo Endosurgery sponsors 7 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 6 completed. The most-studied condition in this pipeline is Obesity, with 1 trials.
Upper-quartile sponsor footprint
Apollo Endosurgery sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
7 total, page 1 of 1
ORBERA™ Post-Approval Study
NCT02828657
A Post-approval LAP-BAND® Lower Body Mass Index (LBMI) Study
NCT02356614
HERO Study: Helping Evaluate Reduction in Obesity
NCT00953173
A Study of BioEnterics® Intragastric Balloon (BIB®) System to Assist in the Weight Management of Obese Subjects
NCT00730327
Effectiveness and Safety Study of LAP-BAND Treatment in Subjects With BMI >/= 30 kg/m2 and < 40 kg/m2
NCT00570505
LAP-BAND AP Early Experience Trial (APEX)
NCT00501085
Effectiveness and Safety Study of LAP-BAND Treatment for Obese Adolescents
NCT00447590
Therapeutic Areas
How the Apollo Endosurgery archive is shaped
7 indexed studies, none listed as recruiting (0% open); 6 completed (86%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Obesity (1 trial), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Apollo Endosurgery: archived-pipeline peers nationwide
Peers matched on 7 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Apollo Endosurgery sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 7 archived trials
- 3M · 7 trials · 0% recruiting
- 4Life Research · 7 trials · 0% recruiting
- 89bio · 7 trials · 29% recruiting
- Abbott Diagnostics Division · 7 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Apollo Endosurgery page
7 registered trials is a research-attention snapshot, not an endorsement of Apollo Endosurgery or any single study.
- None of Apollo Endosurgery's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Obesity is the condition Apollo Endosurgery studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Apollo Endosurgery pipeline card: 7 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.